About: At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: Post-collection acceptability of specimen collection process and patient confidence in specimens

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: Post-collection acceptability of specimen collection process and patient confidence in specimens Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: Post-collection acceptability of specimen collection process and patient confidence in specimens
Creator	Id, Eric Sanchez, Travis Adam, Elizabeth Guest, Jodie Siegler, Aaron Valencia, Rachel Valentine-Graves, Mariah Hardee Id, Isabel Id, Sullivan Sean, Patrick Shinn, Kaitlin
Source	Medline; PMC
abstract	BACKGROUND: Options to increase the ease of testing for SARS-CoV-2 infection and immune response are needed. Self-collection of diagnostic specimens at home offers an avenue to allow people to test for SARS-CoV-2 infection or immune response without traveling to a clinic or laboratory. Before this study, survey respondents indicated willingness to self-collect specimens for COVID-related tests, but hypothetical willingness can differ from post-collection acceptability after participants collect specimens. METHODS: 153 US adults were enrolled in a study of the willingness and feasibility of patients to self-collect three diagnostic specimens (saliva, oropharyngeal swab (OPS) and dried blood spot (DBS) card) while observed by a clinician through a telehealth session. After the specimens were collected, 148 participants participated in a survey about the acceptability of the collection, packing and shipping process, and their confidence in the samples collected for COVID-related laboratory testing. RESULTS: A large majority of participants (>84%) reported that collecting, packing and shipping of saliva, OPS, and DBS specimens were acceptable. Nearly nine in 10 (87%) reported being confident or very confident that the specimens they collected were sufficient for laboratory analysis.There were no differences in acceptability for any specimen type, packing and shipping, or confidence in samples, by gender, age, race/ethnicity, or educational level. CONCLUSIONS: Self-collection of specimens for SARS-CoV-2 testing, and preparing and shipping specimens for analysis, were acceptable in a diverse group of US adults. Further refinement of materials and instructions to support self-collection of saliva, OPS and DBS specimens for COVID-related testing is needed.
has issue date	2020-08-05(xsd:dateTime)
bibo:doi	10.1371/journal.pone.0236775
bibo:pmid	32756585
has license	cc0
sha1sum (hex)	2aa5e0012fabff8d486194827be96aa92c4f96ce
schema:url	https://doi.org/10.1371/journal.pone.0236775
resource representing a document's title	At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: Post-collection acceptability of specimen collection process and patient confidence in specimens
has PubMed Central identifier	PMC7406082
has PubMed identifier	32756585
schema:publication	PLoS One
resource representing a document's body	covid:2aa5e0012fabff8d486194827be96aa92c4f96ce#body_text
is schema:about of	named entity 'tests' named entity 'hypothetical' named entity 'CLINIC' covid:arg/2aa5e0012fabff8d486194827be96aa92c4f96ce named entity 'SARS-CoV-2' named entity 'specimens' named entity 'swabs' named entity 'confidence' named entity 'saliva' named entity 'SARS-CoV-2' named entity 'throat swab' named entity 'saliva' named entity 'telehealth' named entity 'global SARS-CoV-2 pandemic' named entity 'clinical care' named entity 'COVID' named entity 'Facebook' named entity 'HIV' named entity 'United States' named entity 'throat swab' named entity 'antibody testing' named entity 'serology' named entity 'SARS-CoV-2' named entity 'study protocol' named entity 'diagnostic testing' named entity 'PCR testing' named entity 'COVID-19' named entity 'saliva' named entity 'biohazard' named entity 'immune response' named entity 'healthcare workers' named entity 'SARS-CoV-2' named entity 'COVID-19 disease' named entity 'SARS-CoV-2' named entity 'PCR' named entity 'saliva' named entity 'PCR' named entity 'COVID' named entity 'COVID' named entity '1 million' named entity 'Emory University' named entity 'polymerase chain reaction' named entity 'human subjects research' named entity 'COVID' named entity 'demographic groups' named entity 'high-quality' named entity 'saliva' named entity 'ethnicity' named entity 'SARS-CoV-2' named entity 'ethnicity' named entity 'infection' named entity 'SARS-CoV-2' named entity 'personal protective equipment' named entity 'saliva' named entity 'DBS' named entity 'PrEP' named entity 'antibody testing' named entity 'throat swab' named entity 'Amazon' named entity 'saliva' named entity 'SARS-CoV-2' named entity 'saliva' named entity 'COVID' named entity 'non-Hispanic white' named entity 'research studies' named entity 'world's population' named entity 'reviewed and approved' named entity 'COVID' named entity 'infection status' named entity 'United States' named entity 'throat swab'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software